RRRustam Kh. Ravilov

Rustam Kh. Ravilov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rustam Kh. Ravilov has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Isolation and purification of recombinant bovine adenovirus type 3 hexone

    by A. R. Akhunova, A. G. Galeeva, A. I. Yarullin, M. A. Efimova, D. N. Mingaleev, R. Kh. Ravilov

  • Open Access

    Safety and Immunogenicity of Recombinant Adeno‐Associated Virus‐Vectored African Swine Fever Virus Antigens

    by Antonina Galeeva, Marina Efimova, Gennadiy Frolov, Nail Khammadov, Almaz Hisamutdinov, Lenar Garipov, Danil Mingaleev, Rustam Ravilov

    Despite the significant global economic damage caused by African swine fever (ASF) and ongoing developments in the field of specific prevention tools development, safe and effective vaccines are still missing. A critical factor hindering the development of ASF vaccines is the lack of sufficient data on the pathogenesis of the virus, as well as a deep understanding of the virus’ evasion strategies from the innate immune system. Of particular interest in the design of candidate vaccines are viral vectors, especially‐adeno‐associated virus (AAV), which is widely used in gene therapy and is capable of long‐term transgene expression in vivo. This study assessed the safety and immunogenicity of recombinant AAV serotype 2 (rAAV2), into the genome of which the ASF virus B646L (p72) , E183L (p54) , CP530R (pp60), and CP204L (p30) immunodominant genes are integrated. The study design included immunization of pigs with monocistronic and bicistronic constructs based on rAAV2 in different regimens, assessment of the safety and tolerability of a laboratory sample of the vaccine, the biochemical and hematological status of the animals, as well as indicators of humoral and cellular immunity. It was found that rAAV2s in immunizing doses no more than 10 × 10 11 viral particles have satisfactory tolerability, promote the formation of virus‐specific antibodies that remain at a high level at least until the 180 days of the experiment. It has been proven that the use of bicistronic constructs makes it possible to achieve a similar immune response as when introducing a cocktail of monocistronic constructs, which allows to reduce the vector load on the animal’s body. Thus, rAAV2 is a promising platform for the construction of a candidate vaccine against ASF, as it is biologically safe and activates the humoral and cellular immune response, which is extremely important for the formation of a protective immunity.


  • Open Access

    In vivo functional assessment of recombinant adeno-associated viruses carrying genes of protectively significant antigens of the African swine fever virus

    by A. G. Galeeva, M. A. Efimova, G. S. Frolov, D. A. Zubrinkin, A. G. Hisamutdinov, L. N. Garipov, D. N. Mingaleev, R. Kh. Ravilo

    Relevance. African swine fever (ASF) is a viral hemorrhagic disease with exceptionally high mortality in members of the family Suidae, with serious economic consequences associated with production losses, trade restrictions and eradication programs. To date, no effective commercial vaccine against ASF has been developed. Of particular interest in the design of candidate vaccines are viral vectors, in particular the adenoassociated virus of the 2nd serotype (AAV2), which has successfully proven itself as a gene therapy agent. We previously reported the ability of rAAV2 to effectively deliver ASF virus genes B646L, E183L, CP530R, CP204L into porcine cells in vitro.The aim of the study was to evaluate the in vivo functionality of adenoassociated viruses of the 2nd serotype carrying genes of protectively significant antigens of the African swine fever virus.Methods. By cloning pairwise combined genes B646L-CP530R, E183L-CP204L into the pAAV-MCS vector, bicistronic constructs with the self-cleaving P2A peptide were created. Assembly of rAAV2 was accomplished by calcium phosphate transfection of AAV293 cells. After iodixanol density gradient purification, rAAV2 was administered to pigs at a dose of 3 × 1011 viral particles and humoral and cellular immunity was assessed for 180 days. The dynamics of antibody genesis were assessed by indirect ELISA, and immunophenotyping of peripheral blood T-lymphocytes was assessed by flow cytometry.Results. It was found that the developed bicistronic constructs based on rAAV2 are safe and easily tolerated by animals and cause the induction of both humoral and cellular immune responses: the formation of virus-specific antibodies was observed, which persisted until the end of the experiment, as well as increased expression of CD8+ and CD4+ lymphocytes. The AAV platform we propose is a promising tool for creating a vaccine, however, a comprehensive characterization of rAAV2 can only be compiled after assessing its protective effect.

  • Open Access

    Optimization of the protocol for the assembly of recombinant adenoassociated serotype 2 viruses for the delivery of African swine fever virus genes into mammalian cells

    by A. G. Galeeva, M. A. Efimova, E. Yu. Zakirova, A. G. Khammadov, A. G. Khisamutdinov, L. N. Garipov, D. N. Mingaleev, R. K. Ravilov, Н. И. Хаммадов

    African swine fever (ASF) is a highly contagious viral disease of theSuidaefamily representatives, the mortality rate in primary foci of which reaches 100 %. To date, no specific means of preventing ASF have been developed. Despite the fact that researchers have proposed various methods for creating candidate vaccines against ASF, the issue of developing alternative antigenic variants with low reactogenicity and high immunogenicity is still relevant. It is known that the production of recombinant adeno-associated virus, a potential tool for delivering ASF virus target genes into mammalian cells, is influenced by many factors, in particular, the cell line, expression system, cell culture conditions after transfection, and the quality of the initial plasmid DNA. This work presents the results of optimization of the assembly protocol for recombinant AAV2 carrying the major capsid protein gene of the ASFVB646Las a model cargo. During the research, it was established that the protocol used allows to achieve a veritable virus titer of (2.45 ± 0.17) × 107 viral particles per μl, while the share of fully assembled viral capsids accounts for up to (79.3 ± 2.3) % of all genomic copies. When assessing the potential cytopathogenic effect of recombinant AAV2 on target cells (SPEV, porcine MSCs), it was found that high MOI (up to 10,000 viral particles per cell) does not lead to an increase in the proportion of apoptotic cells. The functionality of the developed AAV2-based construct was confirmed: in the lysates of transduced cells, the mature p72 protein with a molecular weight of 73 kDa was detected, specifically reacting in a western blot with hyperimmune pig serum. Our data confirm the potential of AAV2 as a tool for delivering ASF virus genes into porcine cells, which makes it a promising basis for the design of candidate vaccines.


  • Open Access

    Efficient delivery of the immunodominant genes of African swine fever virus by adeno-associated virus serotype 2

    by Rustam Ravilov, Antonina Galeeva, Gennadiy Frolov, Marina Efimova, Elena Zakirova, Albert Rizvanov, Almaz Hisamutdinov, Lenar Garipov, Danil Mingaleev

    Background and Aim: Adeno-associated virus serotype 2 (AAV2) represents a promising basis for developing a virus-vector vaccine against African swine fever (ASF). This study aimed to create genetic constructs based on AAV2 to deliver the immunodominant genes of ASF virus (ASFV) and to evaluate their functionality in vitro. The efficiency and specificity of transgene expression, as well as their non-toxicity in cells of target animals, were evaluated. Materials and Methods: Bioinformatics analysis methods were used to identify the immunodominant genes of ASFV. The target genes B646L, E183L, CP204L, and CP530R were identified and subsequently cloned into the pAAV-MCS vector. Assembly of recombinant AAV2 (rAAV2) was performed by cotransfection of AAV293 cells with the following plasmids: pAAV-MCS with the gene of interest, envelope, and packaging. Quantitative polymerase chain reaction was used to determine the AAV2 titer. The functionality of the constructs was evaluated in HEK293 and SPEV cells by determining the presence of mature proteins in the cell lysate and the expression levels of messenger RNA. The specificity of the target proteins in cell lysates was confirmed by Western blotting. Results: The proposed AAV2 assembly protocol makes it possible to achieve a concentration of mature viral particles of at least 280 billion/mL of virus-containing material. The rAAV2 could effectively transduce host SPEV cells. The expression of both cistrons was detectable during the transduction of cells; therefore, the combined expression of immunogens in the cells of target animals should be possible using this method. Conclusion: This study demonstrated the potential of using genetic constructs based on AAV2 for the delivery of ASFV genes in vitro. Keywords: adeno-associated virus, African swine fever virus, gene delivery, virally vectored vaccine.


  • Open Access

    Analysis of immunodominant African swine fever virus peptides for candidate vaccine design

    by M. A. Efimova, A. G. Galeeva, A. I. Khamidullina, R. Kh. Ravilov

    Relevance. Prevention and control of ASF is significantly hampered by the lack of available vaccines and effective therapeutic measures. The ASF virus is capable of interfering with various cellular signaling pathways, leading to immunomodulation, which makes the development of an effective vaccine extremely difficult. Given the various limitations of known strategies for the development of ASF vaccines, the search for promising platforms for the development of safe and effective drugs to combat the virus is ongoing. The basis for the design of candidate vaccines is the choice of immunogenic peptides that provide stable humoral and cellular immune responses and the identification of potential targets for immune responses.Methods. In this study, 31 candidate amino acid sequences of more than 100 strains and epizootic isolates of the African swine fever virus was analyzed using standard bioinformatic methods.Results. Based on the number of T- and B-cell epitopes identified during the initial analysis, the type and severity of the immune response in target animals, it was found that the proteins p72 (B646L), p30 (CP204L), p54 (E183L), pp62 (CP530R), pp220 (CP2475L) have the greatest immunogenic potential. For the analyzed proteins, the N- and O-glycosylation sites, the localization of signal peptides and transmembrane domains were determined in silico, and their main physicochemical properties were predicted. The application of the proposed approaches made it possible to select potentially immunogenic epitopes of ASFV proteins, which in the future will be used to design new candidate vector vaccines. Given the number of antigenic determinants, the considered proteins, in our opinion, have a significant vaccine potential, however, real data on their immunogenicity will be established during practical testing of the developed vector constructs.


  • Open Access

    Methodology of selection and synthesis of mathematical models of the epizootic process

    by A. I. Bogdanov, B. S. Mongush, В. А. Кузьмин, D. A. Orekhov, R. K. Ravilov, A. M. Gulyukin, A. B. Aidiev, E. A. Gulyukin

    The epizootic process (EP) is a continuous process of the emergence and spread of explicit and latent infections of animals. In some zoonoses, the study of EP by experimental studies can have negative consequences for human health. Therefore, the development of mathematical models of EP is of great practical importance. The purpose of the work is to consider the principles of the methodology for selecting and synthesizing EP models based on the mathematical theory of epidemics (MTE). Of the existing two main types of models are considered - deterministic and stochastic, their advantages and disadvantages are noted in connection with the main parameters used in the modeling of EP. An analytical review of mathematical models of Kermack (W.O.Kermack) and McKendrick; Weiss (George H. Weiss) for the study of EP is presented. Of the existing two main types of models are considered - deterministic and stochastic, their advantages and disadvantages are noted in connection with the main parameters used in the simulation of the EP. The issue of the methodology of selection and synthesis of models of the epizootic process for further forecasting of the most common viral and bacterial diseases of animals using models existing in the mathematical theory of epidemics is considered. The principles of the methodology for the selection and synthesis of MTE models using state graphs and tables of transition intensity models are considered. It is established that the method of selecting a stochastic MTE model for a specific disease or model synthesis uses a table of transition intensity models. It is concluded that the choice between deterministic and stochastic models is determined by the population size, the stage of epizootic/epidemic development, and the requirements for the accuracy of mathematical modeling. The proposed methodology for the selection and synthesis of mathematical models of EP allows you to build a mathematical model for predicting the distress of farms at the regional level. In recent years, there has been a tendency to switch to the use of simulation models and the creation of a bank of mathematical models for predicting epizootic situation indicators based on time series analysis.


  • THERAPEUTIC AND PREVENTIVE EFFECTIVENESS OF THE NEW ANTISEPTIC AGENT REKOBACT IN CATTLE NECROBATERIOSIS

    by Al-Amin Umaru Beiki, D.N. Mingaleev, V.S. Ugryumova, R.KH. Ravilov, O.V. Ugryumov, I.G. Galimzyanov, R.S. Yarullin

  • GENEALOGICAL STRUCTURE OF THE TATARSTAN POPULATION OF THE HOLSTEIN BREED BY BELONGING TO PERSPECTIVE BRANCHES

    by Ch.A. Kharisova, T.M. Akhmetov, R.R. Shaidullin, F.F. Zinnatov, R.KH. Ravilov, R.R. Mullakhmetov

    Изучена генеалогическая структура татарстанской популяции голштинской породы по принадлежности к перспективным ветвям. Цель разведения по линиям заключается в закреплении и развитии в потомстве ценных особенностей родоначальника и его продолжателей. Установлено, что в стаде имеется восемь перспективных ветвей из трех линий, при этом наибольшая доля в популяции молочного скота отводится ветвям Hanoverhill Starbuck 352790 (28,3%), Rockalli Son of Bova 1665634 (28,4%) из линии Вис Бек Айдиала и Arlinda Rotate 1697572 (20,8%) из линии Рефлекшн Соверинга. Немногочисленная группа скота происходит из ветви S-W-D Valiant 1650414 (1,6%). Высоким родословным индексом быка характеризуются животные ветви Sweet-Haven Tradition с удоем 15231 кг, массовой долей жира в молоке - 4,01 % и массовой долей белка - 3,28 % и ветвь Rockalli Son of Bova (14299 кг - 3,83 % - 3,17...